Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

Their results argue for a change to parity between small-molecule agents and biologics when it comes to Inflation Reduction ...

Kebilidi is a one-time gene therapy administered directly to the brain in patients with AADC deficiency, rare genetic ...

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...

In a new study of patients with metastatic non-small cell lung cancer, researchers found that patients who were more physically fit had better outcomes. With lung cancer claiming around 1.8 million ...

Patients with metastatic non-small cell lung cancer, even those with brain metastases, experienced improved longer-term ...

Canadian study reveals that women who undergo early menopause are less at risk for asthma than women who experience menopause ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying ...

The panelist discusses how intrauterine insemination is typically considered for patients with unexplained infertility, mild ...

People with multiple sclerosis (MS) often stop taking disease-modifying therapy as they transition from relapsing-remitting MS to secondary progressive MS. This study shows that people who stop stop ...